Dune submitted a Premarket Application (PMA) in April 2011 based on data from a 600 patient pivotal study conducted primarily in the U.S.
"We are very pleased with the panel's positive decision on the MarginProbe System for use in the U.S.," says Dune's Chief Executive Officer Dan Levangie. "We...
In order to view the entire article, please read your options to the right
If you have an account with NewsRx and have purchased either a NewsRx Bundled package or a NewsRx Pass, you can log into your account below to access this article.
If you are new to NewsRx, you may also take advantage of cost-saving options such as those below to view this article.
View an unlimited number of articles for a day, week, month, etc.
Purchase a bundle of article-viewing-credits that never expire and receive a discount of up to 50%!
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.